奥美医疗股份回购进展：截至10月底累计回购530.62万股 耗资超5000万元

Core Viewpoint - Aomei Medical has successfully executed its share repurchase plan, exceeding the minimum funding requirement and demonstrating commitment to shareholder value [1][3]. Repurchase Plan Background - Aomei Medical's board approved a share repurchase plan on January 20, 2025, intending to use self-owned funds and special loan funds for stock repurchase, aimed at employee stock ownership plans [2]. - The repurchase price ceiling is set at 11.00 CNY per share, with a total funding range of no less than 50 million CNY and no more than 100 million CNY, to be completed within 12 months [2]. Repurchase Implementation Progress - As of October 31, 2025, Aomei Medical has repurchased 5.3062 million shares, representing 0.8379% of the total share capital, at an average price of 10.05 CNY per share, with a total expenditure of 50.6186 million CNY [3]. - The highest transaction price recorded was 10.05 CNY per share, and the lowest was 8.33 CNY per share, both below the set ceiling price [3]. Future Plans - Aomei Medical plans to continue its share repurchase according to market conditions within the remaining timeframe, adhering to relevant regulations and ensuring timely information disclosure [4].